SCHEMBL29857097

SCHEMBL29857097

N#Cc1ccc(C2Oc3ccccc3O2)c(F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 4/20 0.41
CYP11B2 P19099 4/20 0.39
CYP19A1 P11511 2/20 0.39
CYP11B1 P15538 2/20 0.39
CYP17A1 P05093 1/20 0.39
HRH1 P35367 1/20 0.39
KCNH2 Q12809 1/20 0.39
NPC1 O15118 1/20 0.38
EGLN2 Q96KS0 1/20 0.35
HSD17B1 P14061 1/20 0.35
HSD17B2 P37059 1/20 0.35
DRD2 P14416 1/20 0.34
DRD3 P35462 1/20 0.34
CHRNA1 P02708 1/20 0.34
CHRNG P07510 1/20 0.34
CHRNB1 P11230 1/20 0.34
CHRNB2 P17787 1/20 0.34
CHRNB4 P30926 1/20 0.34
CHRNA3 P32297 1/20 0.34
CHRNA4 P43681 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22061829 0.84 DPP4 (0.36) DPP4CYP11B2CYP19A1CYP11B1CYP17A1
SCHEMBL31140530 0.80 MAPT (0.41) DPP4CYP11B2CYP19A1CYP11B1CYP17A1
SCHEMBL22009927 0.79 HTR6 (0.40) DPP4CYP11B2CYP19A1CYP11B1CYP17A1
SCHEMBL29556433 0.79 HTR6 (0.40) DPP4CYP11B2CYP19A1CYP11B1CYP17A1
SCHEMBL122002 0.74 CYP11B2 (0.43) DPP4CYP11B2CYP19A1CYP11B1CYP17A1
SCHEMBL31160051 0.71 CYP11B2 (0.45) DPP4CYP11B2CYP19A1CYP11B1CYP17A1
SCHEMBL28458968 0.71 CYP11B2 (0.45) DPP4CYP11B2CYP19A1CYP11B1CYP17A1
SCHEMBL31192651 0.71 DPP4 (0.44) DPP4CYP11B2CYP19A1CYP11B1CYP17A1
SCHEMBL31192649 0.70 DPP4 (0.38) DPP4CYP11B2CYP19A1CYP11B1CYP17A1
SCHEMBL10501106 0.69 CYP11B2 (0.39) DPP4CYP11B2CYP19A1CYP11B1CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250099431-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2025-03-27 US disclosed
US-12121511-B2 GLP-1R modulating compounds GILEAD SCIENCES, INC. (US) 2024-10-22 US disclosed
US-20220288030-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2022-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12121511-B2 GLP-1R modulating compounds GLP1R, GIPR, GPR119 DPP4 18/4885CYP11B2 3375/4885CYP19A1 3231/4885
US-20250099431-A1 GLP-1R MODULATING COMPOUNDS GLP1R, GIPR, GPR119 DPP4 18/4885CYP11B2 3375/4885CYP19A1 3231/4885
US-20220288030-A1 GLP-1R MODULATING COMPOUNDS GLP1R, GIPR, GPR119 DPP4 18/4885CYP11B2 3375/4885CYP19A1 3231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.